Liquid crystal biochemical sensor and device and method for detecting concentration of biomolecules by using liquid crystal biochemical sensor

Through laser irradiation and voltage driving panels, the optical properties of the liquid crystal box are adjusted, combined with optical path transmission module and image acquisition module, the problems of insufficient detection sensitivity and complex operation of traditional liquid crystal biosensors are solved, label-free biomolecule detection is realized, and detection is improved Accuracy and stability.

CN118914142APending Publication Date: 2024-11-08SHANGHAI YANGPU SHIDONG HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411107710.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Traditional LCD biosensors have insufficient detection sensitivity, high sensitivity to environmental factors, complex operation, and rely on chemical markers to affect the detection results and sample status.

Method used

Design a liquid crystal biochemical sensor to interact with the biomolecules to be tested through laser irradiation, use the voltage-driven panel to adjust the optical properties of the liquid crystal box, realize label-free biomolecule detection, and combine it with the optical path transmission module, image acquisition module and controller to establish Voltage-brightness relationship model, calculate biomolecular concentration.

Benefits of technology

It improves the detection sensitivity of extremely low concentrations of biomolecules, reduces the sensitivity to environmental factors, simplifies the operation process, avoids the use of chemical markers, and achieves fast and accurate biomolecule detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118914142A_ABST
    Figure CN118914142A_ABST
Patent Text Reader

Abstract

The invention relates to a liquid crystal biochemical sensor and a device and a method for detecting the concentration of biomolecules by using the liquid crystal biochemical sensor. The liquid crystal biochemical sensor is designed to interact with biomolecules to be measured through laser irradiation to generate quantifiable optical response. The liquid crystal biochemical sensor comprises a liquid crystal box and a voltage driving panel directly positioned below the liquid crystal box; the liquid crystal box interacts with biomolecules to be detected through laser irradiation to generate optical response; the voltage driving panel is used for adjusting voltage to control the optical property of the liquid crystal box, so that the optical property generates different optical responses according to the concentration of the biomolecules to be detected under laser irradiation. The device for detecting the biomolecule concentration comprises a light path transmission module, a liquid crystal biochemical sensor, an image acquisition module and a controller. According to the device for detecting the concentration of the biomolecules, the concentration of the biomolecules is directly calculated through the liquid crystal biochemical sensor, and the applicability and effectiveness of the device in practical application are remarkably improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of liquid crystal-based biomolecule sensors, and in particular relates to a liquid crystal biochemical sensor and a device and method for detecting the concentration of biomolecules thereof. Background Art

[0002] Liquid crystal (LC) materials have significant potential in the field of biosensing due to their high sensitivity to external stimuli such as electric fields, temperature, and light, especially in detecting changes in biomolecules by exploiting the flexibility of their molecular arrangement. However, although traditional LC biosensors are able to detect biomolecules by monitoring changes in the orientation of LC molecules, these technologies still have several key limitations. First, the detection sensitivity and limit of detection (LOD) of these sensors are usually insufficient to capture low concentrations of biomarkers. Second, LC biosensors are extremely sensitive to environmental factors such as temperature and mechanical vibration, and this sensitivity often leads to unstable results and errors, affecting the reliability and repeatability of the sensors. In addition, the operational complexity of traditional technologies is also a major obstacle. The preparation and use of LC biosensors usually involve complex LC cell preparation, precise surface chemical treatment, and strict temperature control, which not only increase the difficulty of operation, but also limit their practicality in application scenarios that require rapid on-site detection. Moreover, many traditional sensors rely on chemical labels to enhance the detection signal, which not only increases the cost of the test, but also may affect the essential state and function of the biological sample.

[0003] In view of these limitations, a liquid crystal biochemical sensor and a device and method for detecting the concentration of biomolecules provided by the present invention significantly simplify the biosensing process. Summary of the invention

[0004] In view of the deficiencies of the prior art, the present invention provides a liquid crystal biochemical sensor and a device and method for detecting the concentration of biomolecules, so as to solve the problems of sensitivity, stability and operation complexity in the prior art, and realize label-free biomolecule detection.

[0005] To achieve the above object, the present invention provides the following solutions:

[0006] A liquid crystal biochemical sensor, wherein the liquid crystal biochemical sensor interacts with a biomolecule to be detected through laser irradiation to generate an optical response;

[0007] The liquid crystal biochemical sensor includes a liquid crystal cell and a voltage driven panel directly below the liquid crystal cell;

[0008] The liquid crystal cell interacts with the biomolecule to be detected through laser irradiation to generate an optical response;

[0009] The voltage driven panel is used to adjust the voltage to control the optical properties of the liquid crystal box, so that the optical properties produce different optical responses according to the concentration of the biological molecules to be detected under laser irradiation.

[0010] Preferably, the liquid crystal box includes top ITO glass, a liquid crystal layer and bottom ITO glass in order from top to bottom; wherein the bottom ITO glass is connected to the voltage-driven panel via a metal connecting wire;

[0011] The top ITO glass surface is evenly sputtered with ITO, which serves as a common electrode of the liquid crystal box, wherein ITO is a kind of metal transparent oxide;

[0012] The liquid crystal layer acts as a sensing medium in the liquid crystal biochemical sensor for detecting and responding to the presence of biomolecules;

[0013] The bottom ITO glass is processed by a preset patterning process to form a uniformly distributed voltage-controlled array electrode.

[0014] Preferably, the voltage-driven panel includes a CMOS array and a PCB board from top to bottom;

[0015] The PCB board is used to provide a voltage control signal to the CMOS array;

[0016] The CMOS array is used to apply voltage to voltage-controlled array electrodes uniformly distributed at the bottom of the liquid crystal box based on the voltage control signal.

[0017] The present invention also provides a device for detecting the concentration of biomolecules, which uses a liquid crystal biochemical sensor and also includes an optical transmission module, an image acquisition module and a controller;

[0018] The optical transmission module is used to generate and transmit laser light to the surface of the liquid crystal biochemical sensor to stimulate optical response;

[0019] The liquid crystal biochemical sensor is used to interact with the biomolecules to be detected through laser irradiation to generate an optical response;

[0020] The image acquisition module is used to convert the optical response into image data;

[0021] The controller is used to analyze the image data and adjust the liquid crystal biochemical sensor based on the analysis result.

[0022] Preferably, the optical path transmission module includes:

[0023] A laser for generating laser light of a specific wavelength to excite the liquid crystal biochemical sensor;

[0024] A reflector, used for reflecting the laser to the surface of the liquid crystal biochemical sensor;

[0025] A lens, used to focus the laser reflected by the mirror;

[0026] An objective lens, used to amplify the optical properties of the liquid crystal layer in the liquid crystal biochemical sensor;

[0027] The polarizer is used to select light with a specific polarization direction to pass through, and analyze the light reflected or transmitted by the liquid crystal layer based on the light with the specific polarization direction.

[0028] The present invention also provides a method for detecting the concentration of biomolecules, and the method uses the device to detect the concentration of biomolecules, comprising the following steps:

[0029] Based on the brightness changes of liquid crystal molecules in the liquid crystal layer of the liquid crystal biochemical sensor under different voltages, a voltage-brightness relationship model is established;

[0030] The biomolecules to be tested are introduced into the liquid crystal layer, and the voltage of each area of ​​the liquid crystal layer is regulated by a voltage driving panel to adjust the liquid crystal molecules to a specific rotation angle;

[0031] Based on the liquid crystal molecules reaching a specific rotation angle, the liquid crystal layer produces a uniform brightness response, and the voltage values ​​of the corresponding points on the voltage driving panel are recorded;

[0032] Based on the voltage-brightness relationship model, converting the voltage value into liquid crystal molecule brightness distribution data;

[0033] Based on the brightness distribution data of the liquid crystal molecules and the known corresponding biomolecule concentration, a brightness-biomolecule concentration relationship model is established;

[0034] Based on the brightness-biomolecule concentration relationship model, the concentration of the biomolecule to be detected is calculated to complete the entire biomolecule concentration detection process.

[0035] Preferably, the method further comprises introducing a biomolecule to be detected into the liquid crystal layer, and capturing and recording a brightness change image of the liquid crystal molecules when the biomolecule to be detected interacts with the liquid crystal molecules to cause the arrangement of the liquid crystal molecules to change;

[0036] The brightness change image is analyzed in conjunction with high-precision micron-level voltage control technology, and the liquid crystal biochemical sensor is adjusted based on the analysis result to respond to and quantify the concentration change of the biomolecules.

[0037] Preferably, the voltage-brightness relationship model expression is as follows:

[0038] L = 100 × (1-exp (-k × (VV th ) γ )),

[0039] Where L is the brightness percentage of the liquid crystal molecules, V is the measured voltage value, V th is the voltage threshold, k and γ are experimentally determined constants.

[0040] Compared with the prior art, the present invention has the following beneficial effects:

[0041] The novel sensor designed by the present invention utilizes innovative liquid crystal box design and optimized molecular orientation control technology to reversely restore the arrangement state of liquid crystal molecules. The precise regulation of the liquid crystal arrangement by the electric field enables the sensor to detect extremely low concentrations of biological molecules. The presence and activity of biological molecules can be directly monitored without relying on external chemical markers, reducing costs and potential biological hazards. The present invention can more accurately monitor and analyze the behavioral changes of liquid crystals in the presence of biological molecules, thereby achieving rapid and accurate detection of various biomarkers. In addition, this technology opens up a new path for the development of more economical and environmentally friendly biological detection methods by reducing the reliance on complex chemical or biological markers. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] In order to more clearly illustrate the technical solution of the present invention, the following briefly introduces the drawings required for use in the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.

[0043] Figure 1 This is a schematic diagram of the structure of a liquid crystal box in a liquid crystal biochemical sensor according to an embodiment of the present invention;

[0044] Figure 2 The top ITO glass and the bottom ITO glass of the liquid crystal box of the embodiment of the present invention are shown; wherein (a) is the top ITO glass of the liquid crystal box; (b) is the bottom ITO glass of the liquid crystal box;

[0045] Figure 3 This is a schematic diagram of the structure of a liquid crystal biochemical sensor according to an embodiment of the present invention;

[0046] Figure 4 The liquid crystal response after the biomolecules enter the liquid crystal layer according to the embodiment of the present invention;

[0047] Figure 5 Schematic diagram of the structure of a device for detecting the concentration of biomolecules according to an embodiment of the present invention;

[0048] Figure 6 A curve diagram showing the relationship between voltage and brightness of liquid crystal molecules according to an embodiment of the present invention;

[0049] Figure 7 A schematic diagram of the brightness of a liquid crystal cell after adding biomolecules according to an embodiment of the present invention;

[0050] Figure 8 A schematic diagram of a CMOS array voltage corresponding to adjusting a liquid crystal box to the same brightness according to an embodiment of the present invention;

[0051] Fig. 9 4 is a flow chart of a method for detecting the concentration of biomolecules according to an embodiment of the present invention. DETAILED DESCRIPTION

[0052] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0053] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the present invention is further described in detail below with reference to the accompanying drawings and specific embodiments.

[0054] Embodiment 1

[0055] A liquid crystal biochemical sensor that interacts with the biomolecules to be measured through laser irradiation to produce a quantifiable optical response; the working principle of the sensor is to unify the brightness of the liquid crystal molecules by adjusting the voltage on the voltage drive panel, thereby measuring the optical response of the liquid crystal and further calculating the concentration of the biomolecules.

[0056] Specifically, Figure 3 As shown, a liquid crystal biochemical sensor includes a liquid crystal cell and a voltage driven panel directly below the liquid crystal cell;

[0057] like Figure 1 As shown, the liquid crystal box interacts with the biomolecules to be detected through laser irradiation to generate an optical response; in this embodiment, the optical response is reflected in the brightness change of the liquid crystal layer.

[0058] In a further embodiment, the liquid crystal box includes top ITO glass, liquid crystal layer and bottom ITO glass from top to bottom, that is, the liquid crystal layer is sandwiched between two transparent conductive glasses. The bottom ITO glass is connected to the voltage driving panel through a metal connecting wire to achieve accurate voltage input.

[0059] like Figure 2 As shown in (a), the top ITO glass surface is evenly sputtered with ITO, which serves as the common electrode of the liquid crystal box; ITO (indium tin oxide) is a conductive material and a type of metal transparent oxide.

[0060] The liquid crystal layer is used to generate an optical response. In this embodiment, cholesterol liquid crystal (Cholesteric Liquid Crystal, CLC) is selected. Its unique spiral structure allows for reversible arrangement changes under the action of an electric field, thereby achieving precise control of the spectral reflection characteristics of the liquid crystal layer. This change enables the liquid crystal layer to adjust its reflection spectrum according to changes in the external electric field, which is used to accurately detect and respond to the presence of biomolecules. Although cholesterol liquid crystal is used in this embodiment, the liquid crystal layer of the present invention is not limited to this type of liquid crystal. Any liquid crystal material that can undergo reversible optical changes under the action of an electric field, thereby adjusting the spectral reflection characteristics, can be used.

[0061] like Figure 2 As shown in (b), the bottom ITO glass is patterned to form uniformly distributed voltage-controlled array electrodes. The patterns of these electrodes are not limited to squares, but can also be designed into polygons or other shapes to optimize the distribution and uniformity of the electric field in the liquid crystal layer.

[0062] The voltage driven panel is used to adjust the voltage to control the optical properties of the liquid crystal box so that the optical properties produce different optical responses according to the concentration of the biomolecule to be detected under laser irradiation.

[0063] The voltage-driven panel adjusts the voltage applied to the liquid crystal layer through the patterned electrodes of the ITO glass at the bottom of the liquid crystal cell. By precisely controlling the voltage, the arrangement of the liquid crystal molecules can be finely adjusted so that the optical signal of the liquid crystal layer responds to changes in the concentration of the biomolecules to be measured. This regulation allows the liquid crystal biochemical sensor to adjust its optical response according to the specific value of the biomolecule concentration, achieving high-precision biomolecule detection.

[0064] A further implementation method is that the voltage driven panel includes a CMOS array and a PCB board from top to bottom;

[0065] PCB board, used to provide voltage control signals to the CMOS array.

[0066] The CMOS array is used to apply voltage to the voltage-controlled array electrodes evenly distributed at the bottom of the liquid crystal box based on the voltage control signal. As the core component of the voltage-driven panel, the CMOS array has the characteristics of high precision and fast response, which makes the voltage regulation accurate and fast, meeting the needs of fine control of liquid crystal molecules.

[0067] The configuration of the liquid crystal biochemical sensor of the present invention allows the liquid crystal molecules to be finely regulated at the micrometer level. By adjusting the voltage, the rotation angle of the liquid crystal molecules can be changed, thereby affecting its optical properties, such as the refractive index. This precise voltage regulation allows the optical properties of the liquid crystal layer to be customized as needed, achieving high resolution and fast response electro-optical performance. Therefore, whether in biomolecule detection or other applications, the present invention can adjust the visual effect according to specific application requirements, showing the advantages of high precision and high sensitivity.

[0068] Embodiment 2

[0069] Add unknown concentration of biomolecules to be tested into the liquid crystal cell, such as Figure 4 As shown, the interaction between biomolecules and liquid crystal molecules causes the orientation of liquid crystal molecules to change, and this change will affect the optical properties of the liquid crystal, especially the brightness. The present invention relates to a high-precision device for detecting the concentration of biomolecules, using the liquid crystal biochemical sensor described in Example 1, and its structure is as follows Figure 5 As shown, it includes an optical path transmission module, an image acquisition module and a controller;

[0070] An optical transmission module, used for generating and transmitting laser light to the surface of the liquid crystal biochemical sensor to stimulate an optical response;

[0071] A further implementation is that the optical path transmission module includes:

[0072] A laser for generating laser light of a specific wavelength to excite the liquid crystal biochemical sensor; for example, 532 nm or 1550 nm, for exciting the liquid crystal layer so as to observe its optical response under different voltages.

[0073] The reflector is used to reflect the laser to the surface of the liquid crystal biochemical sensor, thereby maximizing the efficiency of light utilization.

[0074] The lens is used to focus the laser reflected by the reflector and enhance its illumination intensity on the liquid crystal layer to improve the observability of the optical effect.

[0075] The objective lens is used to magnify the optical properties of the liquid crystal layer in the liquid crystal biochemical sensor so that tiny changes can be observed in detail.

[0076] The polarizer is used to select light with a specific polarization direction to pass through, and analyze the light reflected or transmitted by the liquid crystal layer based on the light with the specific polarization direction, so as to ensure the accuracy of the obtained data.

[0077] Liquid crystal biochemical sensors are used to interact with the biomolecules to be detected through laser irradiation to produce optical responses;

[0078] The image acquisition module is used to convert the optical response into image data; in this embodiment, the image acquisition module uses a CCD camera.

[0079] The controller is used to analyze the image data and adjust the liquid crystal biochemical sensor based on the analysis results in combination with precise micron-level voltage control technology to accurately change the arrangement and optical properties of the liquid crystal molecules.

[0080] The biomolecule concentration detection device designed by the present invention not only provides a highly accurate method to study and quantify the effect of biomolecules on liquid crystal arrangement, but also achieves precise control of the optical properties of liquid crystals by finely regulating the voltage in the liquid crystal biochemical sensor, thus bringing innovation to biomedical research and biosensing technology. In addition, the design of the system allows for rapid and accurate detection of biomolecule concentrations, greatly enhancing its applicability and effectiveness in practical applications.

[0081] Embodiment 3

[0082] like Fig. 9 As shown, the present invention also provides a method for detecting the concentration of biomolecules, which is used to apply the device of Example 2 to detect the concentration of biomolecules, comprising the following steps:

[0083] S1: Based on the brightness change of the liquid crystal molecules in the liquid crystal layer of the liquid crystal biochemical sensor under different voltages, a voltage-brightness relationship model is established; in this embodiment, a relationship curve between the optical properties of the liquid crystal molecules and the voltage is established. This involves changing the voltage applied to the liquid crystal molecules and observing their optical response. Specifically, Figure 6 As shown, by recording the brightness changes of liquid crystal molecules under different voltages, a voltage-brightness relationship model is established. A further implementation method is that the voltage-brightness relationship model expression is as follows:

[0084] L = 100 × (1-exp (-k × (VV th ) γ )),

[0085] Where L is the brightness percentage of the liquid crystal molecules, V is the measured voltage value, V th is the voltage threshold, k and γ are experimentally determined constants.

[0086] S2: Introduce the biological molecules to be tested into the liquid crystal layer, and finely control the voltage of each area of ​​the liquid crystal layer through the voltage driving panel to adjust the liquid crystal molecules to a specific rotation angle to match the preset brightness standard.

[0087] S3: Based on the liquid crystal molecules reaching a specific rotation angle, the liquid crystal layer produces a uniform brightness response and records the voltage values ​​of the corresponding points on the voltage-driven panel; these data are the key basis for subsequent analysis and calculation of the concentration of biomolecules.

[0088] It should be noted that liquid crystal molecules exhibit different rotation angles under different pressure difference conditions. This process is reversible. Liquid crystal molecules exhibit different optical properties at different rotation angles, such as different refractive indices. Liquid crystal molecules with different refractive indices exhibit different brightness responses under the same light irradiation conditions. Figure 7 This is a schematic diagram of the brightness of the liquid crystal box after adding biological molecules; Figure 8 As shown, these voltage data reflect the degree of influence of biomolecule concentration on liquid crystal orientation.

[0089] S4: Based on the voltage-brightness relationship model, the voltage value is converted into liquid crystal molecule brightness distribution data; this step critically reflects the precise correlation between the optical properties of the liquid crystal layer and the applied voltage.

[0090] S5: establishing a brightness-biomolecule concentration relationship model based on the brightness distribution data of the liquid crystal molecules and the known corresponding biomolecule concentration;

[0091] S6: Based on the brightness-biomolecule concentration relationship model, the concentration of the biomolecule to be tested is obtained after accurate calculation, completing the entire biomolecule concentration (bioactive response, BAR) detection process. This method allows the concentration of biomolecules to be inferred directly from the optical response, provides a detection method without chemical labeling, and enhances the rapidity and accuracy of the detection.

[0092] In this embodiment, the brightness-biomolecule concentration relationship model is: BAR=f(L),

[0093] The specific function f depends on the characteristics of liquid crystal molecules and experimental calibration data.

[0094] A further implementation method is to introduce the biomolecules to be detected into the liquid crystal layer, and when the biomolecules to be detected interact with the liquid crystal molecules to cause the arrangement of the liquid crystal molecules to change, the image acquisition module (such as a CCD camera) described above captures and records the brightness change image of the liquid crystal molecules;

[0095] The brightness change image is analyzed with high-precision micron-level voltage control technology, and the liquid crystal biochemical sensor is adjusted based on the analysis results to respond to and quantify the concentration changes of biomolecules.

[0096] The biomolecule concentration data calculated from the brightness data can provide researchers or clinicians with accurate biological detection results. This method not only improves the detection accuracy, but also simplifies the operation process, making liquid crystal biochemical sensors have broad application prospects in the fields of biomedicine and environmental monitoring.

[0097] The main purpose of the present invention is to control the orientation of liquid crystal molecules through precise voltage-driven arrays, significantly improve the detection sensitivity of low-concentration biomolecules and reduce the detection limit (LOD). In addition, the present invention is intended to enhance the stability and reliability of the sensor under different environmental conditions, reduce errors caused by temperature fluctuations or mechanical vibrations, and improve repeatability. By simplifying the preparation of liquid crystal cells and avoiding complex surface chemical treatments, the present invention simplifies the operation process, reduces the cost of technical implementation, and makes the equipment easier to deploy and use. At the same time, the sensor is designed to respond quickly to changes in biomolecules to meet the needs of rapid diagnosis and real-time data acquisition in emergency situations. The label-free detection method of the present invention avoids the chemical labeling process that may affect the nature of the sample, maintains the original state of the biological sample, and thus provides more accurate and true detection results. By achieving these goals, the present invention will promote the application of liquid crystal biochemical sensing technology in the fields of medical health monitoring, environmental monitoring, and food safety, and provide a more advanced, accurate and user-friendly biomolecule detection solution.

[0098] The embodiments described above are only descriptions of the preferred embodiments of the present invention and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.

Claims

1. A liquid crystal biochemical sensor, characterized in that: The liquid crystal biochemical sensor interacts with the biomolecule to be detected through laser irradiation to generate an optical response; The liquid crystal biochemical sensor includes a liquid crystal cell and a voltage driven panel directly below the liquid crystal cell; The liquid crystal cell interacts with the biomolecule to be detected through laser irradiation to generate an optical response; The voltage driven panel is used to adjust the voltage to control the optical properties of the liquid crystal box, so that the optical properties produce different optical responses according to the concentration of the biological molecules to be detected under laser irradiation.

2. The liquid crystal biochemical sensor according to claim 1, characterized in that: The liquid crystal box includes top ITO glass, liquid crystal layer and bottom ITO glass from top to bottom; wherein the bottom ITO glass is connected to the voltage driving panel through a metal connecting wire; The top ITO glass surface is evenly sputtered with ITO, which serves as a common electrode of the liquid crystal box, wherein ITO is a kind of metal transparent oxide; The liquid crystal layer acts as a sensing medium in the liquid crystal biochemical sensor for detecting and responding to the presence of biomolecules; The bottom ITO glass is processed by a preset patterning process to form a uniformly distributed voltage-controlled array electrode.

3. The liquid crystal biochemical sensor according to claim 1, characterized in that: The voltage driven panel includes a CMOS array and a PCB board from top to bottom; The PCB board is used to provide a voltage control signal to the CMOS array; The CMOS array is used to apply voltage to voltage control array electrodes evenly distributed at the bottom of the liquid crystal box based on the voltage control signal.

4. A device for detecting the concentration of biomolecules, using the liquid crystal biochemical sensor according to any one of claims 1 to 3, characterized in that: It also includes an optical transmission module, an image acquisition module and a controller; The optical transmission module is used to generate and transmit laser light to the surface of the liquid crystal biochemical sensor to stimulate optical response; The liquid crystal biochemical sensor is used to interact with the biomolecules to be detected through laser irradiation to generate an optical response; The image acquisition module is used to convert the optical response into image data; The controller is used to analyze the image data and adjust the liquid crystal biochemical sensor based on the analysis result.

5. The device for detecting the concentration of biomolecules according to claim 4, characterized in that: The optical path transmission module comprises: A laser for generating laser light of a specific wavelength to excite the liquid crystal biochemical sensor; A reflector, used for reflecting the laser to the surface of the liquid crystal biochemical sensor; A lens, used to focus the laser reflected by the mirror; An objective lens, used to amplify the optical properties of the liquid crystal layer in the liquid crystal biochemical sensor; The polarizer is used to select light with a specific polarization direction to pass through, and analyze the light reflected or transmitted by the liquid crystal layer based on the light with the specific polarization direction.

6. A method for detecting the concentration of biomolecules, using the device according to any one of claims 4 to 5 to detect the concentration of biomolecules, characterized in that: The following steps are involved: Based on the brightness changes of liquid crystal molecules in the liquid crystal layer of the liquid crystal biochemical sensor under different voltages, a voltage-brightness relationship model is established; The biomolecules to be tested are introduced into the liquid crystal layer, and the voltage of each area of ​​the liquid crystal layer is regulated by a voltage driving panel to adjust the liquid crystal molecules to a specific rotation angle; Based on the liquid crystal molecules reaching a specific rotation angle, the liquid crystal layer produces a uniform brightness response, and the voltage values ​​of the corresponding points on the voltage driving panel are recorded; Based on the voltage-brightness relationship model, converting the voltage value into liquid crystal molecule brightness distribution data; Based on the brightness distribution data of the liquid crystal molecules and the known corresponding biomolecule concentration, a brightness-biomolecule concentration relationship model is established; Based on the brightness-biomolecule concentration relationship model, the concentration of the biomolecule to be detected is calculated to complete the entire biomolecule concentration detection process.

7. The method for detecting the concentration of biomolecules according to claim 6, characterized in that: The invention also includes introducing the biomolecules to be detected into the liquid crystal layer, and capturing and recording the brightness change image of the liquid crystal molecules when the biomolecules to be detected interact with the liquid crystal molecules to cause the arrangement of the liquid crystal molecules to change; The brightness change image is analyzed in conjunction with high-precision micron-level voltage control technology, and the liquid crystal biochemical sensor is adjusted based on the analysis result to respond to and quantify the concentration change of the biomolecules.

8. The method for detecting the concentration of biomolecules according to claim 6, characterized in that: The voltage-brightness relationship model expression is as follows: L=100×(1-exp(-k×(VV th ) γ )), Where L is the brightness percentage of the liquid crystal molecules, V is the measured voltage value, V th is the voltage threshold, k and γ are experimentally determined constants.